ATR and neoplasm: As a SUMO (small ubiquitin-like modifier)-E3 ligase, the anti-tumor functions of PIAS3 are also associated with sumoylation enhancement and degradation of oncoproteins40–42, as well as a promoting regulation of p53 and ATR by inducing p53 sumoylation43–45.